|
Laboratories
|
Result
|
Reference value
|
|---|
|
At presentation
|
Day 2
|
Day 3
|
Day 5
|
Day 7
|
Day 8
|
|---|
|
Hemoglobin
|
15.2
|
13.7
|
11.6
|
13.1
|
11.4
|
11.2
|
12–16 gr/dl
|
|
Hematocrit
|
43
|
40
|
33
|
38
|
34
|
33
|
36–43%
|
|
Platelets
|
38.700
|
21.000
|
37.200
|
48.200
|
63.400
|
80.000
|
140–440 × 103 × mm3
|
|
Leukocytes
|
32.160
|
12.160
|
7.600
|
6.560
|
8.370
|
10.330
|
4.5–10.5 × 103 × mm3
|
|
Neutrophils
|
19
|
42
| |
31
|
51
|
32
|
35–70%
|
|
Lymphocytes
|
35
|
49
| |
75
|
35
|
10
|
20–45%
|
|
INR
|
2.13
| |
1.82
|
1.41
| |
1.15
| |
|
PTT
| |
52.1
|
44.9
|
39.5
|
36.8
|
30.5
|
Control 30 seconds
|
|
Total bilirubin
|
35
|
15.9
|
13.2
|
10.4
|
4.4
|
4.5
|
0–1 mg/dl
|
|
Direct bilirubin
|
27.5
|
12.4
|
11.0
|
8.5
|
3.4
|
3.2
|
0–0.3 mg/dl
|
|
Indirect bilirubin
|
7.7
|
2.8
|
2.2
|
1.9
|
0.87
|
1.30
|
0–0.7 mg/dl
|
|
AST (SGOT)
|
53
|
48
|
65
|
62
|
53
|
45
|
0–32 UI/ml
|
|
ALT (SGPT)
|
57
|
56
|
50
|
44
|
62
|
56
|
0–31 UI/ml
|
|
Alkaline Phosphatase
|
616
| |
665
| | |
613
|
35–104 UI/ml
|
|
Creatinine
|
1.05
| |
2.3
|
1.62
|
1.6
|
1.3
|
0.4–1.4 mg/dl
|
|
Urea nitrogen
|
13.9
| |
61.9
|
42.3
|
41.0
|
38.5
|
4.6–23.4 g/dl
|
|
Albumin
| |
1.9
| | | | |
3.4–4.8 gr/dl
|
|
Potassium
| |
4.6
| |
3.97
|
4.4
| |
3.5–4.5 mEq/L
|
|
Sodium
| |
136
|
138
|
135
|
138
| |
135–148 mEq/L
|
|
Calcium
| |
7.4
| | | | |
8.6–10.2 g/dl
|
|
Chlorine
| |
105
|
108
| | | |
98–107 mEq/L
|
|
DHL
| |
459
| | | | |
240–480 UI/ml
|
|
GGT
| |
226
| | | | |
5–39 UI/L
|
|
Glycemia
| | |
74
| | | |
70–110 mg/dl
|
|
HIV serology
| | | |
Negative
| | | |
|
Blood cultures
| | | |
Negative
| | | |
|
Peripheral blood Smear
|
Microcytosis, mild anisocytosis. White line with lots of reactive lymphocytes. Hypochromia
|
- ALT alanine aminotransferase, AST aspartate aminotransferase, DHL, GGT gamma-glutamyltransferase, INR international normalized ratio, PTT partial thromboplastin time, SGOT serum glutamic oxaloacetic transaminase, SGPT serum glutamic pyruvic transaminase
